UncategorizedPhotopharmics closes $6 million to advance Parkinson’s device Empower Meds / November 23, 2025
UncategorizedStudy finds inflammation-targeting drug has Parkinson’s potential Empower Meds / November 23, 2025
UncategorizedSenescent skin cells shown to follow three distinct aging paths Empower Meds / November 23, 2025
UncategorizedGranata Bio acquires ovarian longevity biotech Oviva Therapeutics Empower Meds / November 23, 2025
UncategorizedTherini Bio advances neurodegeneration drug to next phase Empower Meds / November 23, 2025
Uncategorized‘We’ve shown that targeting senescent cells can lead to improved outcomes’ Empower Meds / November 23, 2025
UncategorizedStately Bio launches to enhance cell therapy with ML-powered imaging Empower Meds / November 23, 2025
